Methylprednisolone versus intravenous immune globulin as an initial therapy in adult primary immune thrombocytopenia.
Conclusions: These results indicate that neither the early response rate nor the long-term outcome differed between the methyl-Pd and IVIg treatments. However, IVIg induced a complete response more rapidly than did methyl-Pd.
PMID: 29172399 [PubMed - as supplied by publisher]
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Kim CH, Choi YS, Moon JY, Kim DY, Lee SY, Lee HJ, Yun HJ, Kim S, Jo DY, Song IC Tags: Korean J Intern Med Source Type: research
More News: Gammagard Liquid | Internal Medicine | Methylprednisolone | Prednisolone | Privigen | Study | Thrombocytopenia | Toxicology